Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$42.5B |
| 2 |
NVIDIA
NVDA
|
+$2.39B |
| 3 |
Walmart Inc
WMT
|
+$1.17B |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.08B |
| 5 |
JPMorgan Chase
JPM
|
+$808M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.26B |
| 2 |
Amazon
AMZN
|
+$843M |
| 3 |
Xcel Energy
XEL
|
+$674M |
| 4 |
Global Payments
GPN
|
+$623M |
| 5 |
Palantir
PLTR
|
+$577M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.11% |
| 2 | Financials | 7.1% |
| 3 | Communication Services | 5.53% |
| 4 | Consumer Discretionary | 5.34% |
| 5 | Healthcare | 4.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3026
Lineage Cell Therapeutics
LCTX
$267M
| $621K | ﹤0.01% |
393,309
+44,799
| +13% | +$75.5K |
|
3027
Stoneridge
SRI
$208M
| $620K | ﹤0.01% |
128,295
+37,088
| +41% | +$254K |
|
3028
Relmada Therapeutics
RLMD
$549M
| $619K | ﹤0.01% |
88,953
+28,953
| +48% | +$137K |
|
3029
Acadia Pharmaceuticals
ACAD
$4.45B
| $619K | ﹤0.01% |
27,803
-340,501
| -92% | -$8.14M |
|
|
UBFO
3030
DELISTED
United Security Bancshares
UBFO
| $618K | ﹤0.01% |
58,822
-8,433
| -13% | -$88.6K |
|
3031
10x Genomics
TXG
$5.97B
| $618K | ﹤0.01% |
29,098
-288,884
| -91% | -$5.78M |
|
3032
American Public Education
APEI
$917M
| $616K | ﹤0.01% |
10,833
-23,515
| -68% | -$1.08M |
|
3033
Usana Health Sciences
USNA
$429M
| $616K | ﹤0.01% |
35,241
-14,030
| -28% | -$278K |
|
3034
ArcBest
ARCB
$3.33B
| $613K | ﹤0.01% |
6,232
-32,855
| -84% | -$3.11M |
|
3035
BrightView Holdings
BV
$1.3B
| $612K | ﹤0.01% |
51,875
-103,871
| -67% | -$1.34M |
|
|
AEXA
3036
American Exceptionalism Acquisition Corp
AEXA
$558M
| $611K | ﹤0.01% |
+56,460
| New | +$639K |
|
3037
Veritone
VERI
$96.7M
| $611K | ﹤0.01% |
309,977
+43,935
| +17% | +$149K |
|
|
AVR
3038
Anteris Technologies
AVR
$795M
| $610K | ﹤0.01% |
109,922
-38,206
| -26% | -$219K |
|
3039
Arbor Realty Trust
ABR
$979M
| $610K | ﹤0.01% |
79,110
-379,325
| -83% | -$2.96M |
|
3040
Transcat
TRNS
$804M
| $610K | ﹤0.01% |
8,299
-13,625
| -62% | -$959K |
|
3041
O-I Glass
OI
$1.39B
| $607K | ﹤0.01% |
57,774
-188,992
| -77% | -$2.6M |
|
3042
SiriusPoint
SPNT
$3.09B
| $607K | ﹤0.01% |
28,178
-133,475
| -83% | -$2.75M |
|
3043
HCI Group
HCI
$2.29B
| $607K | ﹤0.01% |
3,923
-13,312
| -77% | -$2.18M |
|
3044
The RMR Group
RMR
$343M
| $606K | ﹤0.01% |
39,143
-20,846
| -35% | -$338K |
|
3045
Suzano
SUZ
$10.4B
| $602K | ﹤0.01% |
60,150
+49,500
| +465% | +$500K |
|
3046
iShares Russell 2000 Growth ETF
IWO
$14.4B
| $600K | ﹤0.01% |
1,913
-74,624
| -98% | -$24.8M |
|
3047
Galicia Financial Group
GGAL
$7.9B
| $600K | ﹤0.01% |
12,846
-23,532
| -65% | -$1.14M |
|
3048
ICU Medical
ICUI
$4.14B
| $599K | ﹤0.01% |
4,636
-33,069
| -88% | -$4.75M |
|
3049
Arvinas
ARVN
$529M
| $597K | ﹤0.01% |
56,357
-112,050
| -67% | -$1.39M |
|
3050
Eagle Bancorp
EGBN
$866M
| $595K | ﹤0.01% |
23,914
-41,544
| -63% | -$1.04M |
|
Similar funds
Barclays's Q1 2026 Portfolio in Review
As of Q1 2026, Barclays held 5,572 positions worth $416B, down 0.11% from $417B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Barclays deployed $19.3B of net new capital in Q1 2026, opening 398 new positions and adding to 1,219 existing holdings. Its largest new stake was Sunbelt Rentals Holdings: 1,528,635 shares worth $99.5M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 20% a quarter earlier, followed by Financials and Communication Services.
On the sell side, the largest reduction was Tesla, an estimated $1.26B trimmed.
- Barclays's largest Q1 2026 buy was Sunbelt Rentals Holdings: 1,528,635 shares worth $99.5M.
- Barclays added most to iShares MSCI Emerging Markets ETF in Q1 2026, an estimated $42.5B increase.
- Barclays's biggest Q1 2026 reduction was Tesla, cutting an estimated $1.26B.
- Barclays fully exited CyberArk in Q1 2026, selling an estimated $232M.
- Barclays's ten largest holdings make up 37% of its $416B portfolio in Q1 2026.
- Barclays opened 398 new positions and closed 564 in Q1 2026.
- Barclays's portfolio value fell 0.11% quarter-over-quarter to $416B.
Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.